{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:28:44Z","timestamp":1768339724500,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.carrev.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T05:28:21Z","timestamp":1612589301000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice"],"prefix":"10.1016","volume":"34","author":[{"given":"Stefano","family":"Galli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altin","family":"Palloshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Contarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Varbella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Caramanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioel Gabrio","family":"Secco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpiero","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.02.003_bb0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.02.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.003978","article-title":"Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease","volume":"9","author":"Testa","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12872-016-0207-5","article-title":"Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention","volume":"16","author":"Tenekecioglu","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.carrev.2021.02.003_bb0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4244\/EIJV12I7A137","article-title":"Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016","volume":"12","author":"Fajadet","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.02.003_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.02.003_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.02.003_bb0035","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.02.003_bb0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4244\/EIJ-D-17-00254","article-title":"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"13","author":"Haude","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.02.003_bb0045","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.jacc.2017.04.011","article-title":"Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents","volume":"69","author":"Sorrentino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.02.003_bb0050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.117.028479","article-title":"Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: a meta-analysis of randomized controlled trials","volume":"135","author":"Montone","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.02.003_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.carrev.2016.05.001","article-title":"In vitro performance investigation of bioresorbable scaffolds - standard tests for vascular stents and beyond","volume":"17","author":"Schmidt","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2021.02.003_bb0060","doi-asserted-by":"crossref","first-page":"73450","DOI":"10.4244\/EIJ-D-17-00499","article-title":"State of the art: the inception, advent and future of fully bioresorbable scaffolds","volume":"13","author":"Katagiri","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.actbio.2009.10.006","article-title":"Developments in metallic biodegradable stents","volume":"6","author":"Hermawan","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.carrev.2021.02.003_bb0070","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","article-title":"Current status of bioresorbable scaffolds in the treatment of coronary artery disease","volume":"64","author":"Wiebe","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.02.003_bb0075","series-title":"Biomaterials science: an introduction to materials in medicine","author":"Ratner","year":"2004"},{"key":"10.1016\/j.carrev.2021.02.003_bb0080","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.3390\/ijms12074250","article-title":"Biodegradable metals for cardiovascular stent application: interests and new opportunities","volume":"12","author":"Moravej","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.carrev.2021.02.003_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.02.003_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCRESAHA.117.310275","article-title":"Bioresorbable scaffold: the emerging reality and future directions","volume":"120","author":"Sotomi","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2021.02.003_bb0095","doi-asserted-by":"crossref","first-page":"24492","DOI":"10.3390\/ijms141224492","article-title":"Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease","volume":"14","author":"Campos","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.carrev.2021.02.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: Magmaris versus Absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0105","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jcin.2017.09.041","article-title":"The state of the Absorb bioresorbable scaffold: consensus from an expert panel","volume":"10","author":"Bangalore","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0110","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.02.003_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4244\/EIJ-D-16-00915","article-title":"Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model","volume":"13","author":"Waksman","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.02.003_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/heart.89.6.651","article-title":"Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?","volume":"89","author":"Heublein","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2021.02.003_bb0125","first-page":"607","article-title":"Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries","volume":"68","author":"Waksman","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0130","first-page":"1","article-title":"BIOSOLVE-IV-registry: safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients","author":"Verheye","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0135","first-page":"E287","article-title":"Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry","volume":"93","author":"Wlodarczak","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.02.003_bb0140","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4244\/EIJ-D-17-00248","article-title":"The drug-eluting absorbable magnesium vascular scaffold in complex coronary bifurcations: insights from an in-vivo multimodality imaging study","volume":"13","author":"Bennett","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.02.003_bb0145","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction. The MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.02.003_bb0150","first-page":"529","article-title":"Why treat chronic total occlusion without stents? A short comment","volume":"8","author":"K\u00f6ln","year":"2017","journal-title":"J Clin Exp Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:22:00Z","timestamp":1761560520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"alternative-id":["S1553838921000853"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.02.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SICI-GISE Position Document on the Use of the Magmaris Resorbable Magnesium Scaffold in Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}